ARTIFICIAL TEARS Eye Drops Recalled for Sterility Concerns, 720 Bottles Distributed Nationwide (2026
Lack of Assurance of Sterility
1,079 recalls tagged with “chemical hazard”.
Lack of Assurance of Sterility
May be temperature abused, which may result in growth of Clostridium botulinum
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Teva-affiliated Clonidine Transdermal System recalls 113,943 cartons after CGMP deviations. Unapproved raw material prompts recall. Stop use immediately and contact Teva or a healthcare provider for guidance.
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
Label declares cream cheese but does not declare milk
CGMP Deviations: use of an unapproved raw material
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Chiesi USA recalled 7,235 Curosurf vials distributed nationwide to hospitals and clinics. The recall cites a lack of assurance of sterility. Healthcare providers should stop using the product immediately and contact Chiesi USA for guidance.
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
FDA analysis revealed the presence of undeclared sildenafil
FDA analysis revealed the presence of undeclared sildenafil and Tadalafil
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
FDA analysis revealed the presence of undeclared sildenafil